5 Key Takeaways

• 1

  The AAP released its 2025 immunization schedule for children, approved by seven medical organizations including the CDC.

• 2

  Changes include a shift from quadrivalent to trivalent influenza vaccines and the addition of cell-culture inactivated influenza vaccine.

• 3

  New guidance specifies nirsevimab for RSV prevention in infants born between October and March, with administration during birth hospitalization.

• 4

  The Meningococcal B vaccination schedule now includes a two-dose Bexsero series for patients aged 16 to 23 years.

• 5

  The complete vaccination schedules are available on the AAP and CDC websites, with instructions for reporting adverse events.